Minerva Neurosciences (NERV) Intangibles (2013 - 2024)
Minerva Neurosciences (NERV) posted Intangibles of $4257.0 for Q2 2024, down 60.0% on a QoQ basis from $10642.0 in Q1 2024, and down 85.71% year-over-year from $29797.0 in Q3 2023.
Minerva Neurosciences (NERV) Intangibles (2013 - 2024) Analysis & Trends
Minerva Neurosciences' Intangibles history runs 12 years deep, the most recent figure standing at $4257.0 for Q2 2024.
- Quarterly Intangibles fell 85.71% year-over-year to $4257.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $4257.0 (down 85.71% YoY) and the FY2023 annual result came in at $17027.0, down 60.0% from the prior year.
- Intangibles was $4257.0 for Q2 2024 at Minerva Neurosciences, down from $10642.0 in the prior quarter.
- Across five years, Intangibles topped out at $15.2 million in Q1 2020 and bottomed at $4257.0 in Q2 2024.
- A 5-year average of $5.1 million and a median of $51080.0 in 2021 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2020 — Intangibles changed 0.0% — and 2021, when it plunged 99.66%.
- Minerva Neurosciences' Intangibles stood at $15.2 million in 2020, then plunged by 99.66% to $51080.0 in 2021, then dropped by 16.67% to $42567.0 in 2022, then plunged by 60.0% to $17027.0 in 2023, then tumbled by 75.0% to $4257.0 in 2024.
- Business Quant data shows NERV's Intangibles at $4257.0 in Q2 2024, $10642.0 in Q1 2024, and $17027.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Minerva Neurosciences | 195.10 Mn | 195.10 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 4,257.00 |
| Mar 31, 2024 | 10,642.00 |
| Dec 31, 2023 | 17,027.00 |
| Sep 30, 2023 | 23,412.00 |
| Jun 30, 2023 | 29,797.00 |
| Mar 31, 2023 | 36,182.00 |
| Dec 31, 2022 | 42,567.00 |
| Sep 30, 2022 | 48,952.00 |
| Jun 30, 2022 | 51,080.00 |
| Mar 31, 2022 | 51,080.00 |
| Dec 31, 2021 | 51,080.00 |
| Sep 30, 2021 | 51,080.00 |
| Jun 30, 2021 | 15.20 Mn |
| Mar 31, 2021 | 15.20 Mn |
| Dec 31, 2020 | 15.20 Mn |
| Sep 30, 2020 | 15.20 Mn |
| Jun 30, 2020 | 15.20 Mn |
| Mar 31, 2020 | 15.20 Mn |
| Dec 31, 2019 | 15.20 Mn |
| Sep 30, 2019 | 34.20 Mn |